Stoke Therapeutics
STOK
STOK
118 hedge funds and large institutions have $715M invested in Stoke Therapeutics in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
7.05% less ownership
Funds ownership: 117.62% → 110.57% (-7%)
14% less capital invested
Capital invested by funds: $828M → $715M (-$113M)
80% less call options, than puts
Call options by funds: $94K | Put options by funds: $475K
Holders
118
Holding in Top 10
3
Calls
$94K
Puts
$475K
Top Buyers
| 1 | +$8.93M | |
| 2 | +$6.26M | |
| 3 | +$5.89M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.49M |
| 5 |
RI
RTW Investments
New York
|
+$5.25M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$18.7M | |
| 3 | -$15.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$14.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.91M |